Ginkgo Bioworks Holdings Inc expected to post a loss of 8 cents a share - Earnings Preview

Ginkgo Bioworks Holdings

07/08/2024 03:07

* Ginkgo Bioworks Holdings Inc  DNA.N   DNA  is expected
to show a
fall in quarterly revenue when it reports  results on August 8
for the period ending June 30 2024
    * The Boston Massachusetts-based  company is expected to
report a
46.5% decrease in revenue to $43.136 million from $80.57 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Ginkgo Bioworks Holdings
Inc
is for a loss of 8 cents per share. 
    * The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 4 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ginkgo
Bioworks
Holdings Inc is $0.30​, above​ its last closing price of $0.29.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.08       -0.08      -0.08     Met     4
 Dec. 31 2024  -0.10       -0.10      -0.11     Missed  -13.8
 Sep. 30 2023  -0.08       -0.09      -0.16     Missed  -86.7​
 Jun. 30 2023  -0.07       -0.08      -0.09     Missed  -6.8
 ​​Mar.        -0.09       -0.09      -0.11     Missed  -22.2
 31 2023                                                
 Dec. 31 2022  -0.21       -0.21      -0.09     Beat    56.8​
 Sep. 30 2022  -0.30       -0.30      -0.41     Missed  -38.5
 Jun. 30 2022  -0.05       -0.04      -0.43     Missed  -892.4
 This summary was machine generated August 7 at 02:07 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)